COVID-19 information and response
  • HOME
  • WHO WE ARE
    • About Us
      • CHS is a local, not-for-profit organisation. We understand the local context, make use of local expertise and strategic partnerships to ensure we implement evidence-informed solutions and interventions to existing and emerging public health concerns.
      • Learn more >>
    • More About Us
      • Our Approach
      • Our Strategic Goals
      • Our Solutions
    • Leadership & Partners
      • Board and Leadership
      • Partners
  • WHAT WE DO
    • Our Solutions
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • Learn More >>
    • Current Programmes
      • Tamatisha TB
      • Shinda Tena
      • TIBU LIMS Secure Sync Project
    • Our Impact
      • Our Impact
      • Focus Areas
      • Tuberculosis in Kenya
    • Past Programmes
      • TIFA Project
      • TB ARC II
      • TB ARC
      • Diagnostics Project
      • Tibulims Project
      • Ezesha_99DOTS Project
      • Tegemeza Plus
      • Shinda
      • Tegemeza
      • Naishi
      • Fikia
      • Afya Info
      • ALHIV Adherence Initiative
  • MEDIA CENTRE
    • News
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • View >>
    • Blog
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • View >>
    • Personal Stories
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • View >>
    • More
      • Video Gallery
  • RESOURCES
    • Papers
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • View >>
    • Job Aids and Tools
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • View >>
    • Best Practices
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • View >>
    • More
      • Annual Reports
      • Newsletters
      • Publications
  • GET INVOLVED
    • Careers
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • View Careers >>
    • Partner With Us
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • Learn more >>
    • Subscribe
      • CHS continues to grow as the preferred partner for health solutions by consistently focusing on the delivery of quality services and continuous improvement in a transparent and accountable manner.
      • Subscribe >>
  • CONTACT US
+321 123 4567
info@test.com
My Account

Why Drug and Alcohol Abuse Puts you at High Risk of Suffering from Tuberculosis (TB)

Posted on February 3, 2022

People who abuse drugs or alcohol have a greater risk of contracting Tuberculosis (TB). The use of drugs and excessive consumption of alcohol damages a person’s organs and weaken their defences (immune system) against illnesses such as TB.

Drug and alcohol abusers may not access a diet that provides all the nutrients needed to stay healthy; they may fail to adhere to their treatment which may lead to drug-resistant TB and they may also spend time in places where it’s easier for TB to spread, such as crowded or poorly ventilated homes or social venues.

TB patients with a substance abuse problem may not access health services in time and if they do, they may fail to adhere to their medication and take it as prescribed. Untreated TB is highly contagious and may be fatal when left untreated, this means they pose an increased risk of passing infectious TB on to others and developing drug-resistant TB.

TB treatment can also be complicated for drug users and alcohol abusers because the combination of these and TB medication may lead to liver toxicity, which is particularly dangerous for people who drink too much alcohol. Injecting drug users are at risk of co-infection with viral hepatitis and HIV, which require careful monitoring and alternative drug regimens.

Drug use and injection drug use are essential factors in tuberculosis (TB) epidemiology in developed and developing countries. While the incidence of TB in most industrialized nations has declined over the past decade, the burden of disease is increasingly borne by urban sub-populations, including drug users. Recognizing the important relationship between TB and drug use, the World Health Organization (WHO), UNAIDS and the UN Office on Drugs and Crime (UNODC) issued a set of guidelines to better coordinate TB care among drug users.

Drug use has been associated with a higher prevalence of latent TB infection (LTBI) and incidence of TB disease. Several studies have characterized the LTBI prevalence (10%–59%) among various cohorts of drug users.

The most effective way to reduce TB incidence and mortality is to interrupt transmission. This requires finding and treating individuals with TB disease early, including those with subclinical disease.

Spatial clustering of individuals with higher rates of progression from infection to diseases, such as those with HIV and malnourishment, can also form transmission hotspots. Illicit drug users have higher TB infection prevalence and disease incidence compared to non-users, likely due to significant within-group transmission and clustered vulnerability.

Increased transmission among people who use illicit drugs (PWUD) could result from the creation of more efficient TB transmitters, increased close contact among transmitters, increased rates of primary progression from infection to disease among contacts, or a combination. Therefore, the interrogation of illicit drug user networks for TB transmission holds great potential as a target for early case identification and linkage to treatment, with the potential benefits of halting transmission to the broader population.

 

This opinion piece was published by the Star Newspaper – Written by NACADA in collaboration with CHS

 

Search

About CHS

CHS is a local, not-for-profit organisation. We understand the local context, make use of local expertise and strategic partnerships to ensure we implement evidence-informed solutions and interventions to existing and emerging public health concerns. Learn more >>

Recent Posts

  • Pre-qualification of suppliers for the supply of goods and provision of services from April 1, 2026, to March 31, 2027 December 5, 2025
  • Kenya’s Charge to End TB November 19, 2025
  • Kenya Takes a Bold Step Towards Ending TB and Advancing Lung Health! November 6, 2025
  • Kenya International Scientific Lung Health Conference: Uniting Innovation and Collaboration for a Healthier Nation October 4, 2025
  • Insights from a Presentation: Cross-border TB Management in Western Kenya September 16, 2025

News & Features

News
Blog
Case Studies
Personal Stories
Newsletters
Annual Reports
Job Aids & Tools
Meeting Reports
Papers
Events

Quick Links

Our Programs
Focus Areas
HIV/AIDS in Kenya
Tuberculosis in Kenya
One
Our Impact
Our Finances

Get Involved

Careers
Partner
Subscribe

Facebook
Twitter
LinkedIn
YouTube

2023. Center for Health Solutions – Kenya(CHS)

Watermark Business Park | Spring Court | First Floor | Ndege Road, Karen